Alexion plans to launch eculizumab in Japan
Alexion's accelerated plans for the launch of Soliris in Japan are based on recent approval of the price for Soliris in Japan by an advisory committee of Japan's Ministry of Health, Labour and Welfare.
Ossiam will launch an emerging markets ETF on the London, Frankfurt, Milan and Paris stock exchanges later this month.